Literature DB >> 30328021

Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis and meta-regression.

Qingqing Liu1,2, Jin Yang1,2, Hairong He1, Yong Yu3, Jun Lyu4,5.   

Abstract

This study aimed to explore whether interleukin-10 polymorphisms are associated with susceptibility to rheumatoid arthritis (RA). Studies that have analyzed the associations of the interleukin-10-1082G>A, -592C>A, and -819C>T polymorphisms with RA were searched for in PubMed and EMBASE. Sensitivity and cumulative analyses were conducted to measure the robustness of our findings. Egger's linear regression and Begg's funnel plots were performed to analyze publication bias. The source of heterogeneity was analyzed by subgroup analysis and meta-regression. This meta-analysis involved 2661 RA patients and 3249 controls in 16 studies. There were significant associations with RA in the AG vs AA model (OR = 0.79, 95% CI = 0.67-0.93, P < 0.01) and the AG + GG vs AA model (OR = 0.80, 95% CI = 0.69-0.93, P < 0.01) for the interleukin-10-1082G>A polymorphism, in the TC vs TT model (OR = 0.61, 95% CI = 0.44-0.84, P < 0.01) and the CC vs TT model (OR = 0.64, 95% CI = 0.46-0.89, P < 0.01) for the interleukin-10-819C>T polymorphism, and in the AC vs AA model (OR = 0.73, 95% CI = 0.56-0.96, P = 0.03) and the AC + CC vs AA model (OR = 0.68, 95% CI = 0.47-0.98, P = 0.04) for the interleukin-10-592C>A polymorphism. Meta-regression revealed that the genotyping method was a major cause of heterogeneity in the AC vs AA model and the AC + CC vs AA model for the interleukin-10-592C>A polymorphism. This meta-analysis showed the interleukin-10-1082G>A, -592C>A, and -819C>T polymorphisms are correlated with the susceptibility to RA. Meta-regression indicated that the genotyping method is a major driver of heterogeneity in the relationship between the interleukin-10-592C>A polymorphism and RA.

Entities:  

Keywords:  Interleukin-10; Meta-analysis; Polymorphism; Rheumatoid arthritis

Mesh:

Substances:

Year:  2018        PMID: 30328021     DOI: 10.1007/s10067-018-4329-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic Macedonians.

Authors:  Dejan Trajkov; Snezhana Mishevska-Perchinkova; Anzelika Karadzova-Stojanoska; Aleksandar Petlichkovski; Ana Strezova; Mirko Spiroski
Journal:  Clin Rheumatol       Date:  2009-08-07       Impact factor: 2.980

2.  Targeting IL-10 in auto-immune diseases.

Authors:  Guo Tian; Jiao-Long Li; De-Guang Wang; Dian Zhou
Journal:  Cell Biochem Biophys       Date:  2014-09       Impact factor: 2.194

Review 3.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Diet and alcohol as risk factors for rheumatoid arthritis: a nested case-control study.

Authors:  B Sundström; I Johansson; S Rantapää-Dahlqvist
Journal:  Rheumatol Int       Date:  2014-11-27       Impact factor: 2.631

Review 5.  New insights into the molecular mechanism of interleukin-10-mediated immunosuppression.

Authors:  Gerald Grütz
Journal:  J Leukoc Biol       Date:  2004-11-02       Impact factor: 4.962

6.  Aberrant expression of interleukin-10 in rheumatoid arthritis: Relationship with IL10 haplotypes and autoantibodies.

Authors:  J Hernández-Bello; E Oregón-Romero; M Vázquez-Villamar; S García-Arellano; Y Valle; J R Padilla-Gutiérrez; I V Román-Fernández; C A Palafox-Sánchez; G E Martínez-Bonilla; J F Muñoz-Valle
Journal:  Cytokine       Date:  2017-02-27       Impact factor: 3.861

7.  Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population.

Authors:  Deepali Gambhir; Able Lawrence; Amita Aggarwal; Ramnath Misra; Sudhir Kumar Mandal; Sita Naik
Journal:  Rheumatol Int       Date:  2009-09-25       Impact factor: 2.631

8.  Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients.

Authors:  Omer Ates; Gulen Hatemi; Vedat Hamuryudan; Aysegul Topal-Sarikaya
Journal:  Clin Rheumatol       Date:  2008-04-22       Impact factor: 2.980

Review 9.  Association of atopic dermatitis with smoking: A systematic review and meta-analysis.

Authors:  Robert Kantor; Ashley Kim; Jacob P Thyssen; Jonathan I Silverberg
Journal:  J Am Acad Dermatol       Date:  2016-08-16       Impact factor: 11.527

10.  Association of the -1082 G/A promoter polymorphism of interleukin-10 gene with the autoantibodies production in patients with rheumatoid arthritis.

Authors:  Petr Nemec; Monika Pavkova-Goldbergova; Jindra Gatterova; Zdenek Fojtik; Anna Vasku; Miroslav Soucek
Journal:  Clin Rheumatol       Date:  2009-03-24       Impact factor: 2.980

View more
  4 in total

1.  The efficacy and safety of Huangqi Guizhi Wuwu decoction for rheumatoid arthritis: A protocol for systematic review and meta-analysis.

Authors:  Lei Wang; Yihua Fan; Ping Xin; Yuetong Zhao; Huaihan Deng; Bo Jia
Journal:  Medicine (Baltimore)       Date:  2020-09-04       Impact factor: 1.889

Review 2.  Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response.

Authors:  Dmitry S Mikhaylenko; Marina V Nemtsova; Irina V Bure; Ekaterina B Kuznetsova; Ekaterina A Alekseeva; Vadim V Tarasov; Alexander N Lukashev; Marina I Beloukhova; Andrei A Deviatkin; Andrey A Zamyatnin
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

Review 3.  Etiologies of Rheumatoid Arthritis: Update on Mucosal, Genetic, and Cellular Pathogenesis.

Authors:  Vanessa L Kronzer; John M Davis
Journal:  Curr Rheumatol Rep       Date:  2021-03-01       Impact factor: 4.592

4.  Dose-dependent effects of oleuropein administration on regulatory T-cells in patients with rheumatoid arthritis: An in vitro approach.

Authors:  Zahra Yousefi; Zahra Mirsanei; Fatemeh S Bitaraf; Sepideh Mahdavi; Mehdi Mirzaii; Reza Jafari
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.